Healthcare & Life Sciences
CoVBio
United States
acquiredacquired
acquired
Stage
About
CoVBio develops booster vaccines and therapeutics targeting SARS-2 beta coronavirus variants, including a pan-sarbecovirus vaccine designed to protect against future variants and zoonotic coronavirus crossovers.
Explore CoVBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.